Voya Financial Advisors Inc. Sells 104 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Voya Financial Advisors Inc. decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.1% during the 4th quarter, HoldingsChannel reports. The firm owned 1,371 shares of the medical equipment provider’s stock after selling 104 shares during the quarter. Voya Financial Advisors Inc.’s holdings in Intuitive Surgical were worth $722,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Nebula Research & Development LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth $809,000. Rothschild Capital Partners LLC acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $311,000. Kovitz Investment Group Partners LLC increased its stake in Intuitive Surgical by 4.3% during the 4th quarter. Kovitz Investment Group Partners LLC now owns 7,775 shares of the medical equipment provider’s stock valued at $4,058,000 after purchasing an additional 324 shares in the last quarter. Topsail Wealth Management LLC bought a new position in Intuitive Surgical in the 4th quarter valued at about $290,000. Finally, Keyvantage Wealth LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth $271,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In related news, VP Fredrik Widman sold 810 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the sale, the vice president now directly owns 473 shares of the company’s stock, valued at approximately $271,397.94. This represents a 63.13 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 in the last ninety days. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Up 4.1 %

Shares of ISRG opened at $508.13 on Friday. The firm has a market cap of $180.99 billion, a price-to-earnings ratio of 79.27, a PEG ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 52 week low of $367.39 and a 52 week high of $616.00. The stock has a 50 day moving average of $513.65 and a 200-day moving average of $532.19.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period in the previous year, the company posted $1.50 EPS. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. Leerink Partners lifted their target price on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Bernstein Bank upped their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. Citigroup raised their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Finally, JPMorgan Chase & Co. raised their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $598.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.